ATE75473T1 -
1,6-NAPHTHYRIDINE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICALS CONTAINING THEM FOR THE TREATMENT OF VASCULAR DISEASES.
- Google Patents
1,6-NAPHTHYRIDINE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICALS CONTAINING THEM FOR THE TREATMENT OF VASCULAR DISEASES.
Info
Publication number
ATE75473T1
ATE75473T1AT87102398TAT87102398TATE75473T1AT E75473 T1ATE75473 T1AT E75473T1AT 87102398 TAT87102398 TAT 87102398TAT 87102398 TAT87102398 TAT 87102398TAT E75473 T1ATE75473 T1AT E75473T1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19863605743external-prioritypatent/DE3605743A1/en
Application filed by Goedecke AgfiledCriticalGoedecke Ag
Application grantedgrantedCritical
Publication of ATE75473T1publicationCriticalpatent/ATE75473T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
1,6-Naphthyridine derivs. of formula (I) and their salts are new where R1 = opt. substd., opt. fused aryl or heteroaryl; R2 = 1-4C alkyl or benzyl; R3 = H, 1-4C alkyl or 2-4C alkoxycarbonyl; R4 = (a) 1-21C hydrocarbyl, opt. contg. O, S, N or halogen atoms and opt. substd. by carbocyclic or heterocyclic ring systems, or (b) NH2, CN, CHO or dihalomethyl; R5 = (a) 2-21C alkoxycarbonyl or opt. substd. carbamoyl, opt. contg. O, S or N atoms and opt. substd. by carbocyclic or heterocyclic ring systems, or (b) COOH.
AT87102398T1986-02-221987-02-20
1,6-NAPHTHYRIDINE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICALS CONTAINING THEM FOR THE TREATMENT OF VASCULAR DISEASES.
ATE75473T1
(en)
HETEROCYCLIC SUBSTITUTED IMIDAZOLIDINES, METHOD AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
4-OXO-THIAZOLIDIN-2-YLIDENE-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICALS CONTAINING THEM FOR COMBATING CENTRAL NERVOUS SYSTEM DISEASES.